COVID-19 Reports

COVID-19: Nigeria Expecting Additional 41m Doses Of Vaccines – NPHCDA

Published

3 years ago

Jul 14, 2021.

Shuaib said the AstraZeneca and Pfizer COVID-19 vaccines are expected through the COVID-19 Vaccines Global Assess Facility (COVAX)

The federal government has disclosed that it is expecting 41,282,770 doses of COVID-19 vaccines by the end of September 2021.

Executive Director of the National Primary Health Care Development Agency (NPHCDA), Faisal Shuaib, disclosed at a briefing on Tuesday that the expected dose is a combination of the Oxford-AstraZeneca, Pfizer-Bio-N Tech/Moderna and Johnson & Johnson (J&J) COVID-19 vaccines.

Shuaib said the AstraZeneca and Pfizer COVID-19 vaccines are expected through the COVID-19 Vaccines Global Assess Facility (COVAX) while the Jassen vaccines are expected from the African Union Commission.

He said, “We have received communication for the delivery of the following vaccine shipments in the coming months. 3,924,000 doses of Oxford/AstraZeneca/Moderna by end of July or early August 2021 from the COVAX facility.

COVID-19

“3,930,910 doses of Pfizer-Bio-N Tech/Moderna COVID-19 vaccine in August from the COVAX facility donated by the United States Government, 3,577,860 doses of Pfizer-Bio-N Tech/Moderna COVID-19 vaccine in Q3 from the COVAX facility

“29,850,000 doses of Johnson & Johnson (Jassen) COVID-19 vaccine by the end of September will arrive in batches from the African Union Commission.”

According to him, the government is putting in place all necessary logistics for storage, distribution, security, and accountability for the range of vaccines expected.

YOU MAY ALSO LIKE

EKO HOT BLOG

Advertise or Publish a Story on EkoHot Blog:

Kindly contact us at [email protected]. Breaking stories should be sent to the above email and substantiated with pictorial evidence.

Citizen journalists will receive a token as data incentive.

Call or Whatsapp: 0803 561 7233, 0703 414 5611